A registry for patients with Short Bowel Syndrome

• Research type

  Research Study

• Full title

  A Prospective, Multi-center Registry for Patients with Short Bowel Syndrome

• IRAS ID

  183578

• Contact name

  Farooq Rahman

• Contact email

  farooq.rahman@uclh.nhs.uk

• Sponsor organisation

  NPS Pharmaceuticals, Inc.

• Clinicaltrials.gov Identifier

  N/A, ENCePP; NCT01990040, Clinicaltrials.gov

• Duration of Study in the UK

  15 years, 0 months, 31 days

• Research summary

  This study is a single-group, prospective, observational, multi-centre (ie, world-wide) registry designed to collect data on long-term safety and clinical outcomes in SBS patients. The primary objective of this study is to evaluate the long-term safety profile for patients with short bowel syndrome (SBS)who are treated with teduglutide in a routine clinical setting and secondarily to evaluate long-term clinical outcomes in this patients.

• REC name

  London - South East Research Ethics Committee

• REC reference

  15/LO/1564

• Date of REC Opinion

  19 Oct 2015

• REC opinion

  Further Information Favourable Opinion